Key statistics
As of last trade, Ardelyx Inc (41X:MUN) traded at 5.61, 84.00% above the 52 week low of 3.05 set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.14 |
---|---|
High | 6.14 |
Low | 5.61 |
Bid | 5.81 |
Offer | 5.86 |
Previous close | 6.15 |
Average volume | 1.01k |
---|---|
Shares outstanding | 235.43m |
Free float | 231.67m |
P/E (TTM) | -- |
Market cap | 1.61bn USD |
EPS (TTM) | -0.2788 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 16:25 BST.
More ▼
Announcements
- Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
- Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
- Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
- Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
- Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024
- Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines
- To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
- Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines
- Ardelyx, Inc. Reports Employment Inducement Grants
- Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
More ▼